Results 61 to 70 of about 45,299 (154)

Drug repurposing in status epilepticus

Epilepsy & Behavior
The treatment of status epilepticus (SE) has changed little in the last 20 years, largely because of the high risks and costs of new drug development for SE. Moreover, SE poses specific challenges to drug development, such as patient diversity, logistical hurdles, and the need for acute treatment strategies that differ from chronic seizure prevention ...
openaire   +2 more sources

Editorial: Molecular modeling in drug repurposing. [PDF]

Front Mol Biosci
Filipe HAL, Garcia-Fandiño R, Piñeiro Á, Fernandez-Lozano C.   +3 more
europepmc   +1 more source

Viral Sentry AI-Automated zoonotic surveillance and drug repurposing agent. [PDF]

Biol Methods Protoc
Munteanu CR, Vázquez-Naya J, Tejera E.
europepmc   +1 more source

Generating explainable hypotheses for drug repurposing with graph neural networks. [PDF]

Sci Rep
Perdomo-Quinteiro P, Guney E, Belmonte-Hernández A.   +2 more
europepmc   +1 more source

Drug-Induced Phospholipidosis as an Artifact in Antiviral Drug Repurposing. [PDF]

ACS Omega
Glenn IS, Paris L, White AD, Garda VG, Montano M, Khalid MM, Kao AW, Ott M, Shoichet BK.   +8 more
europepmc   +1 more source

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework. [PDF]

Acta Oncol
Abel E, Östling P, Hallersjö Hult E, Kulbacka K, Babacic H, Baan A, Carneiro A, De Petris L, Fagman H, Friesland S, Frisell O, Hellström M, Lindahl G, Steen Carlsson K, Tamborero D, Valachis A, Öhlund D, Lehtiö J, Rosenquist R, Edsjö A, FOCU.SE trial group.   +20 more
europepmc   +1 more source

Breaking glycolysis: allosteric hotspots for multi-target drug repurposing. [PDF]

J Comput Aided Mol Des
Vural LS, Kahraman E, Mintemur S, Urhan S, Akten ED.   +4 more
europepmc   +1 more source

DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing. [PDF]

Curr Issues Mol Biol
Muddather HF, Schelz Z, Zupkó I.
europepmc   +1 more source

KG-bench: benchmarking graph neural network algorithms for drug repurposing. [PDF]

Bioinformatics
Wei S, Sasi C, Piepenbrock J, Huynen MA, 't Hoen PAC, SIMPATHIC Consortium .   +5 more
europepmc   +1 more source

Therapeutic Potential of Ambroxol in Osteoarthritis: A Drug Repurposing Study. [PDF]

Pharmaceuticals (Basel)
Mesquita MJTAM, Cruz ACSND, Teixeira JTAMMM, Reis ATF, Frota GM, Carvalho TGPM, Carvalho RAF, Teixeira JAM, Andrade MS, Carvalho RC, Sousa EM, Sousa JCS, de Morais SV, Silva ER, Cartágenes MDSS, Garcia JBS.   +15 more
europepmc   +1 more source